drug · Product Intelligence

Nabiximols
Pipeline Intelligence

Nabiximols: 2 indexed trials, 2 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.

⚗
2Indexed trials
▦
2Sponsors
⌁
0Orange Book patent links
◎
0FDA-linked events

Development evidence

NCT04984278Jazz Pharmaceuticals · multiple_sclerosisPHASE3
NCT05974293Michael, Levy M.D.,Ph.D. · multiple_sclerosisPHASE2

FDA / patent evidence

No FDA Orange Book product match is asserted for this intervention.

Regulatory context

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.